Let's talk medical research

Electronic patient-reported outcomes (ePROs) in a clinical trial allow patients to answer questions about side effects, symptoms, and quality of life on their own electronic device, or one provided by the study. When used effectively, ePRO in clinical trials can improve both data quality and the overall patient experience.

Randomization and Trial Supply Management (RTSM) technology is one of the driving forces behind every clinical trial. However, because it’s such a behind-the-scenes technology, many clinical trial managers may not be up-to-date on its latest advances — or about changes on the horizon.

An Interactive Web Response System (IWRS) is the technology clinical trial managers use to randomize patients into a trial and to track drug supply. Since maintaining the integrity of a blinded study and sustaining drug supply levels are two of the most important parts of a clinical trial, it’s essential to know how your IWRS works and what to look for when choosing a system.

Recruiting patients for a clinical trial can be a complex process. There are many things to keep track of from outreach to enrollment, whether managing the process in-house or working with a clinical trial recruitment company.

Whether you’re using a clinical trial patient recruitment company or creating ads in-house, your ad design can make or break your recruitment success. Katrina Ambrose, Antidote’s Senior Designer, Marketing, shared how she applies design thinking to clinical trial advertising.

The Foundation for Peripheral Neuropathy is a nonprofit organization whose ultimate goal is to dramatically improve the lives of those living with peripheral neuropathy (weakness, numbness, and pain caused by nerve damage). The Foundation serves as the premier resource for information for patients, families, and healthcare providers. By funding collaborative efforts of leading scientists, The ...

We caught up with Jack Burks, MD, of the Multiple Sclerosis Association of America (MSAA) to find out his thoughts on what’s new and exciting in Multiple Sclerosis research. Here’s what he had to say:

If you’ve been diagnosed with an illness, you probably know the accompanying feeling of uncertainty all too well. How will this impact your life? What treatment will you select? Will there be side effects? Will it work?

We’ve long followed the Scrip Awards - where the industry’s highest achievers are recognized for outstanding work across the drug development spectrum. And now, we’re thrilled to announce that Antidote has been named a Scrip Awards finalist in two different categories: “Best Technological Development in Clinical Trials,” for our product Antidote Match, and “Community Partnership of the Year” for ...

It’s been an exciting fall here at Antidote. We announced our latest round of funding, grew our partner network to more than 210 partners, and are now finalists for two Scrip Awards. The Scrip Awards provide the industry with the opportunity to recognize its highest achievers across the drug development spectrum— from novel deals, to new drug launches, to technological breakthroughs in clinical ...